REVIEW
|
doi:10.20944/preprints202010.0234.v1
Subject:
Medicine And Pharmacology,
Clinical Medicine
Keywords:
myostatin inhibition; Duchenne Muscular Dystrophy; skeletal muscle; muscle development; clinical trials; translation
Online: 12 October 2020 (12:07:43 CEST)